JP2011503137A5 - - Google Patents

Download PDF

Info

Publication number
JP2011503137A5
JP2011503137A5 JP2010533548A JP2010533548A JP2011503137A5 JP 2011503137 A5 JP2011503137 A5 JP 2011503137A5 JP 2010533548 A JP2010533548 A JP 2010533548A JP 2010533548 A JP2010533548 A JP 2010533548A JP 2011503137 A5 JP2011503137 A5 JP 2011503137A5
Authority
JP
Japan
Prior art keywords
vitro
interleukin
incubating
analogues
microorganism
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010533548A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011503137A (ja
Filing date
Publication date
Priority claimed from EP07120713A external-priority patent/EP2060586A1/en
Application filed filed Critical
Publication of JP2011503137A publication Critical patent/JP2011503137A/ja
Publication of JP2011503137A5 publication Critical patent/JP2011503137A5/ja
Pending legal-status Critical Current

Links

JP2010533548A 2007-11-14 2008-11-10 新規のアルギニン置換ペプチド及びその使用 Pending JP2011503137A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07120713A EP2060586A1 (en) 2007-11-14 2007-11-14 New synthetic arginine substituted peptides and their use
US99006607P 2007-11-26 2007-11-26
PCT/EP2008/065186 WO2009062898A1 (en) 2007-11-14 2008-11-10 New synthetic arginine substituted peptides and their use

Publications (2)

Publication Number Publication Date
JP2011503137A JP2011503137A (ja) 2011-01-27
JP2011503137A5 true JP2011503137A5 (enExample) 2012-01-05

Family

ID=39226731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010533548A Pending JP2011503137A (ja) 2007-11-14 2008-11-10 新規のアルギニン置換ペプチド及びその使用

Country Status (9)

Country Link
US (2) US7928185B2 (enExample)
EP (2) EP2060586A1 (enExample)
JP (1) JP2011503137A (enExample)
CN (1) CN101878226B (enExample)
AU (1) AU2008323041A1 (enExample)
CA (1) CA2703894A1 (enExample)
DK (1) DK2212352T3 (enExample)
MX (1) MX2010005280A (enExample)
WO (1) WO2009062898A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2481751A1 (en) 2011-01-26 2012-08-01 PharmaSurgics in Sweden AB Human lactoferrin derived peptides
WO2014090905A1 (en) * 2012-12-11 2014-06-19 Imaxio Modified coiled coil type proteins having improved properties
JP2016520534A (ja) 2013-03-18 2016-07-14 イマクシオImaxio インフルエンザ核タンパク質ワクチン
US9850278B2 (en) 2013-04-25 2017-12-26 Carmel-Haifa University Economic Corp. Synthetic anti-inflammatory peptides and use thereof
US12295990B2 (en) 2018-11-09 2025-05-13 The Wistar Institute Of Anatomy And Biology Use of lactoferrin for generating myeloid-derived suppressor cells

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2818056B2 (ja) 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
JP3347819B2 (ja) 1993-06-28 2002-11-20 森永乳業株式会社 抗菌性ペプチドの精製方法
JP3529423B2 (ja) 1994-04-01 2004-05-24 森永乳業株式会社 抗菌性ペプチドの製造方法
JP3812957B2 (ja) 1994-08-02 2006-08-23 森永乳業株式会社 角膜損傷治療剤
JPH08143468A (ja) 1994-11-17 1996-06-04 Morinaga Milk Ind Co Ltd 抗潰瘍剤
JP2001504447A (ja) 1996-08-12 2001-04-03 エイプラス サイエンス インベスト アーベー ラクトフェリンおよび/またはラクトフェリシンでの、感染、炎症および/または腫瘍の処置および予防
SE9804614A0 (en) * 1998-07-06 2000-01-07 A+ Science Invest Ab New peptides and use thereof
US6399570B1 (en) * 1999-02-05 2002-06-04 Agennix, Inc. Antimicrobial/endotoxin neutralizing polypeptide
CA2388910C (en) * 1999-11-11 2008-10-07 Am-Pharma B.V. Antimicrobial activity of the first cationic cluster of human lactoferrin
US7183381B2 (en) 2004-10-26 2007-02-27 Agennix, Inc. Composition of lactoferrin related peptides and uses thereof

Similar Documents

Publication Publication Date Title
Rada et al. Reactive oxygen species mediate inflammatory cytokine release and EGFR-dependent mucin secretion in airway epithelial cells exposed to Pseudomonas pyocyanin
Chen et al. The gamma interferon receptor is required for the protective pulmonary inflammatory response to Cryptococcus neoformans
JP2011503137A5 (enExample)
Maris et al. Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers
Tanabe et al. Airway goblet cells secrete pro-inflammatory cytokines, chemokines, and growth factors
Sayers et al. Role of cyclooxygenase-2 in exacerbation of allergen-induced airway remodeling by multiwalled carbon nanotubes
CN112106705B (zh) 一种评价药物预防病毒性肺炎效果的方法
WO2023061512A1 (zh) 体外细胞因子风暴模型及其构建方法和应用
Lora et al. FcεRI-dependent gene expression in human mast cells is differentially controlled by T helper type 2 cytokines
CN104928288A (zh) 一种用于我国养殖对虾虾肝肠胞虫感染早期预警的套式引物及其应用
CN105412112A (zh) Roquefortine F在制备治疗慢性阻塞性肺疾病药物中的应用
Ghassemi-Golezani et al. Influence of hydro-priming on reserve utilization of differentially aged chickpea seeds
CN102154185B (zh) 一株产咖啡酸的刺五加内生细菌
Lee et al. Evidence-guided optimization of herbal formula Cheong-Hwa-Bo-Um-Tang using multiplex cytokine profiling
sites Prevalence et al. First reported detection of Batrachochytrium dendrobatidis in Florida, USA
CN119827767B (zh) 泛素特异性蛋白酶usp4在治疗急性肺损伤/急性呼吸窘迫综合征中的应用
CN204540371U (zh) 从王台中取幼虫的多排镊子
CN101057840A (zh) Vam3在制备治疗慢性阻塞性肺疾病的药物中的应用
CN102703327B (zh) 产乌头碱的枝孢菌xj-ac03及其应用
CHO et al. Comparison of Cytokine and Chemokine Production and Activation of NF-kappaB in RSV-and Adenovirus-infected Bronchial Epithelial Cells
CN102988377B (zh) Houttuynoid D在制备治疗慢性阻塞性肺疾病的药物中的应用
CN102988383B (zh) Houttuynoid E在制备治疗慢性阻塞性肺疾病的药物中的应用
Caprio et al. The effects of skin psoriasis inflammation on adipose tissue-derived mediators and viceversa
CN103120672A (zh) Aphanamixoid A在治疗慢性阻塞性肺疾病的药物中的应用
Campbell et al. Cytokine and chemokine interactions in allergic airway inflammation